Intranasal ondansetron microemulsion counteracting the adverse effects of cisplatin: animal study.

Mai MansourMaha NasrOmar A H Ahmed-FaridRania F Ahmed

Published in: Pharmacological reports : PR (2022)

Ondansetron microemulsion can be administered by an alternative route of administration (intranasal) rather than oral, for patients on cisplatin chemotherapy.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
chemotherapy induced
emergency department
radiation therapy
locally advanced
rectal cancer
drug induced